All In Biotech

Drug Trial Radar · NCT07055516

Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes

Last checked: Nov 19, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 176 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

176

Actual

Start

May 8, 2025

Primary completion

May 27, 2026

Study completion May 27, 2026

Sponsor

Sponsor type
Industry
First posted
Jul 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.

Conditions

  • Obesity and Type 2 Diabetes

Interventions

  • NT-0796Drug

    Orally administered capsules

  • PlaceboDrug

    Orally administered capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ratio Change in hsCRP in participants with obesity and without T2DM hsCRPTime frame: Baseline to Week 24
  2. Change in body weight in participants with obesity with and without T2DMTime frame: Baseline to Week 24

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Investigative site

    Mesa, Arizona

  • Investigative site

    Los Angeles, California

  • Investigative site

    Cooper City, Florida

  • Investigative Site

    Hialeah, Florida

  • Investigative Site

    Jacksonville, Florida

  • Investigative Site

    Miami, Florida

  • Investigative Site

    Port Orange, Florida

  • Investigative Sites

    Marrero, Louisiana

  • Investigative Site

    Columbus, Ohio

  • Investigative Site

    Dallas, Texas

  • Investigative Site

    Manassas, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.